ArticleClinical and translational medicine2022

Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastoma.

Maïté Verreault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.